Skip to main content
Clinical Trials/ACTRN12622000618752
ACTRN12622000618752
Not yet recruiting
未知

Patient-reported outcomes following platelet-rich plasma (PRP) compared to corticosteroid intra-articular injection for treatment of adhesive capsulitis: A randomised controlled trial

Dr Matthew Brick0 sites200 target enrollmentApril 26, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Adhesive capsulitis shoulder (frozen shoulder)
Sponsor
Dr Matthew Brick
Enrollment
200
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 26, 2022
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Matthew Brick

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 years or over living in Auckland region
  • Specialist\-confirmed diagnosis of adhesive capsulitis
  • Shoulder pain and restricted range of motion in shoulder
  • Symptoms between 1\-12 months
  • Shoulder radiograph and ultrasound scan. Radiology will document capsular thickness, bursal thickness, prevalence of co\-existing calcific tendonitis, rotator cuff tendinopathy/minor tear or joint effusion. These findings are not exclusion criteria.

Exclusion Criteria

  • Serious orthopaedic or medical co\-morbidity including osteoarthritis, fracture, dislocation, massive rotator cuff tear, infection, malignancy, haematological disorder, chronic regional pain syndrome of the shoulder, crystal arthropathy of shoulder confirmed on previous aspirate, previous shoulder injection within 3 months
  • Participants need to avoid steroids and non\-steroidal anti\-inflammatories (NSAID) in the week prior and week after their injection. This will be screened for during the consent process and immediately before the procedure. Patients using these medications will be deferred to a later procedure day when they haven’t used them for over one week prior.

Outcomes

Primary Outcomes

Not specified

Similar Trials